Methods

Published on 31 May 2024

ReCorDE: a framework for identifying drug classes targeting shared vulnerabilities with applications to synergistic drug discovery

in Pharmacology of Anti-Cancer Drugs

August J. John
Emily T. Ghose
Huanyao Gao
Meagan Luck
Dabin Jeong
Krishna R. Kalari
Liewei Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1343091

989 views

Original Research

Published on 08 May 2024

The application of Global Trigger Tool in monitoring antineoplastic adverse drug events: a retrospective study

in Pharmacology of Anti-Cancer Drugs

Yang Liu
Xianjun Liu
Binbin Xia
Jing Chen
Wenfang Sun
Fang Liu
Hua Cheng

Frontiers in Oncology

doi 10.3389/fonc.2024.1230514

764 views

Original Research

Published on 01 May 2024

Electrochemical DNA-nano biosensor for the detection of Goserelin as anticancer drug using modified pencil graphite electrode

in Pharmacology of Anti-Cancer Drugs

Layla Abd-Al-Sattar Sadiq Laylani
F. Al-dolaimy
Ali Altharawi
Ghasen M. Sulaman
Mohammed Ahmed Mustafa
Adnan Taan Alkhafaji
Ali G. Alkhatami

Frontiers in Oncology

doi 10.3389/fonc.2024.1321557

2,762 views

Original Research

Published on 30 Apr 2024

In silico evaluation of anti-colorectal cancer inhibitors by Resveratrol derivatives targeting Armadillo repeats domain of APC: molecular docking and molecular dynamics simulation

in Pharmacology of Anti-Cancer Drugs

Shopnil Akash
Md. Rezaul Islam
Abdul Ali Bhuiyan
Mirza Nafeul Islam
Imren Bayıl
Rasha Mohammed Saleem
Ghadeer M. Albadrani
Muath Q. Al-Ghadi
Mohamed M. Abdel-Daim

Frontiers in Oncology

doi 10.3389/fonc.2024.1360745

2,259 views
1 citation

Review

Published on 30 Apr 2024

Regulatory considerations in the design, development and quality of monoclonal antibodies and related products for the diagnosis and treatment of cancer

in Pharmacology of Anti-Cancer Drugs

Marjorie A. Shapiro

Frontiers in Oncology

doi 10.3389/fonc.2024.1379738

4,412 views
3 citations

Original Research

Published on 25 Apr 2024

Body composition and inflammation variables as the potential prognostic factors in epithelial ovarian cancer treated with Olaparib

in Pharmacology of Anti-Cancer Drugs

Xingzi Guo
Jie Tang
Haifeng He
Lian Jian
Ouyang Qiang
Yongzhi Xie

Frontiers in Oncology

doi 10.3389/fonc.2024.1359635

1,161 views

Review

Published on 23 Apr 2024

Cancer related cognitive impairment: a downside of cancer treatment

in Pharmacology of Anti-Cancer Drugs

Kimberly Demos-Davies
Jessica Lawrence
Davis Seelig

Frontiers in Oncology

doi 10.3389/fonc.2024.1387251

2,337 views
2 citations

Original Research

Published on 16 Apr 2024

Role of proteoglycan synthesis genes in osteosarcoma stem cells

in Pharmacology of Anti-Cancer Drugs

Ryoma Osumi
Kengo Sugihara
Makoto Yoshimoto
Kazuya Tokumura
Yuki Tanaka
Eiichi Hinoi

Frontiers in Oncology

doi 10.3389/fonc.2024.1325794

1,463 views
1 citation

Editorial

Published on 05 Apr 2024

Editorial: Overcoming obstacles of cancer immunotherapy: the important role of emerging nanomedicine

in Pharmacology of Anti-Cancer Drugs

Aimin Jiang
Wangxiao He
Yu Yao

Frontiers in Oncology

doi 10.3389/fonc.2024.1406244

796 views
1 citation

Editorial

Published on 04 Apr 2024

Editorial: Advances in molecular and pharmacological mechanisms of novel targeted therapies for melanoma

in Pharmacology of Anti-Cancer Drugs

Marcel Henrique Marcondes Sari
Luana Mota Ferreira

Frontiers in Oncology

doi 10.3389/fonc.2024.1403778

500 views

Review

Published on 25 Mar 2024

Research progress on the antitumor effects of harmine

in Pharmacology of Anti-Cancer Drugs

Yonghua Hu
Xiaoli Yu
Lei Yang
Gaimei Xue
Qinglin Wei
Zhijian Han
Hao Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1382142

2,266 views
1 citation

Original Research

Published on 21 Mar 2024

Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune response on drug exposure

in Pharmacology of Anti-Cancer Drugs

Anna Spreafico
Eva Muñoz Couselo
Anja Irmisch
Juliana Bessa
George Au-Yeung
Oliver Bechter
Inge Marie Svane
Miguel F. Sanmamed
Valentina Gambardella
Meredith McKean

Frontiers in Oncology

doi 10.3389/fonc.2024.1346502

4,204 views

Original Research

Published on 20 Mar 2024

Pyroptosis-related gene signature for predicting gastric cancer prognosis

in Pharmacology of Anti-Cancer Drugs

Salem Saeed Saad Khamis
Jianhua Lu
Yongdong Yi
Shangrui Rao
Weijian Sun

Frontiers in Oncology

doi 10.3389/fonc.2024.1336734

1,434 views
1 citation

Case Report

Published on 07 Mar 2024

Immune checkpoint inhibitor-related acquired amegakaryocytosis thrombocytopenia: a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Valérian Rivet
Vincent Sibaud
Jérémie Dion
Thibaut Volosov
Mélanie Biteau
Andréa Pastissier
Karen Delavigne
Pierre Cougoul
Odile Rauzy
Thibault Comont

Frontiers in Oncology

doi 10.3389/fonc.2024.1353896

1,437 views
1 citation

Original Research

Published on 07 Mar 2024

Photodynamic therapy with paclitaxel-encapsulated indocyanine green-modified liposomes for breast cancer

in Pharmacology of Anti-Cancer Drugs

Mariko Ishizuka
Masaki Kaibori
Fusao Sumiyama
Yoshiharu Okamoto
Akiko Suganami
Yutaka Tamura
Kengo Yoshii
Tomoharu Sugie
Mitsugu Sekimoto

Frontiers in Oncology

doi 10.3389/fonc.2024.1365305

2,151 views

Original Research

Published on 26 Feb 2024

Localized radiotherapy of solid tumors using radiopharmaceutical loaded implantable system: insights from a mathematical model

in Pharmacology of Anti-Cancer Drugs

Anahita Piranfar
Mohammad Souri
Arman Rahmim
Madjid Soltani

Frontiers in Oncology

doi 10.3389/fonc.2024.1320371

1,590 views
7 citations

Navigation group

Articles

ReCorDE: a framework for identifying drug classes targeting shared vulnerabilities with applications to synergistic drug discovery

The application of Global Trigger Tool in monitoring antineoplastic adverse drug events: a retrospective study

Electrochemical DNA-nano biosensor for the detection of Goserelin as anticancer drug using modified pencil graphite electrode

In silico evaluation of anti-colorectal cancer inhibitors by Resveratrol derivatives targeting Armadillo repeats domain of APC: molecular docking and molecular dynamics simulation

Regulatory considerations in the design, development and quality of monoclonal antibodies and related products for the diagnosis and treatment of cancer

Body composition and inflammation variables as the potential prognostic factors in epithelial ovarian cancer treated with Olaparib

Cancer related cognitive impairment: a downside of cancer treatment

Role of proteoglycan synthesis genes in osteosarcoma stem cells

Editorial: Overcoming obstacles of cancer immunotherapy: the important role of emerging nanomedicine

Editorial: Advances in molecular and pharmacological mechanisms of novel targeted therapies for melanoma

Research progress on the antitumor effects of harmine

Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune response on drug exposure

Pyroptosis-related gene signature for predicting gastric cancer prognosis

Immune checkpoint inhibitor-related acquired amegakaryocytosis thrombocytopenia: a case report and literature review

Photodynamic therapy with paclitaxel-encapsulated indocyanine green-modified liposomes for breast cancer

Localized radiotherapy of solid tumors using radiopharmaceutical loaded implantable system: insights from a mathematical model